 | • レポートコード：MRC23Q37804 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、70ページ • 納品方法：Eメール（2-3日） • 産業分類：医療 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の麻疹/風疹ワクチン市場について調査・分析し、世界の麻疹/風疹ワクチン市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（一価ワクチン、多価ワクチン）、用途別セグメント分析（病院、クリニック、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Serum Institute of India Ltd.、Merck & Co. Inc.、GlaxoSmithKline Inc.、Takeda Pharmaceutical Companyなどが含まれています。 世界の麻疹/風疹ワクチン市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、麻疹/風疹ワクチン市場規模を推定する際に考慮しました。本レポートは、麻疹/風疹ワクチンの世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、麻疹/風疹ワクチンに関するビジネス上の意思決定に役立てることを目的としています。 ・麻疹/風疹ワクチン市場の概要 - 製品の定義 - 麻疹/風疹ワクチンのタイプ別セグメント - 世界の麻疹/風疹ワクチン市場規模：タイプ別分析（一価ワクチン、多価ワクチン） - 麻疹/風疹ワクチンの用途別セグメント - 世界の麻疹/風疹ワクチン市場規模：用途別分析（病院、クリニック、その他） - 世界の麻疹/風疹ワクチン市場規模予測（2018年-2029年） - 麻疹/風疹ワクチンの平均価格推移（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - 麻疹/風疹ワクチン市場の競争状況およびトレンド ・麻疹/風疹ワクチンの地域別市場規模 - 北米の麻疹/風疹ワクチン市場規模（2018年-2029年） - アメリカの麻疹/風疹ワクチン市場規模（2018年-2029年） - ヨーロッパの麻疹/風疹ワクチン市場規模（2018年-2029年） - アジア太平洋の麻疹/風疹ワクチン市場規模（2018年-2029年） - 中国の麻疹/風疹ワクチン市場規模（2018年-2029年） - 日本の麻疹/風疹ワクチン市場規模（2018年-2029年） - 韓国の麻疹/風疹ワクチン市場規模（2018年-2029年） - インドの麻疹/風疹ワクチン市場規模（2018年-2029年） - オーストラリアの麻疹/風疹ワクチン市場規模（2018年-2029年） - 中南米の麻疹/風疹ワクチン市場規模（2018年-2029年） - 中東・アフリカの麻疹/風疹ワクチン市場規模（2018年-2029年） ・タイプ別セグメント：一価ワクチン、多価ワクチン - 世界の麻疹/風疹ワクチンのタイプ別販売量（2018年-2023年） - 世界の麻疹/風疹ワクチンのタイプ別売上（2018年-2023年） - 世界の麻疹/風疹ワクチンのタイプ別価格 ・用途別セグメント：病院、クリニック、その他 - 世界の麻疹/風疹ワクチンの用途別販売量（2018年-2023年） - 世界の麻疹/風疹ワクチンの用途別売上（2018年-2023年） - 世界の麻疹/風疹ワクチンの用途別価格 ・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向 Serum Institute of India Ltd.、Merck & Co. Inc.、GlaxoSmithKline Inc.、Takeda Pharmaceutical Company ・産業チェーンと販売チャネルの分析 - 麻疹/風疹ワクチン産業チェーン分析 - 麻疹/風疹ワクチンの主要原材料 - 麻疹/風疹ワクチンの販売チャネル - 麻疹/風疹ワクチンのディストリビューター - 麻疹/風疹ワクチンの主要顧客 ・麻疹/風疹ワクチン市場ダイナミクス - 麻疹/風疹ワクチンの業界動向 - 麻疹/風疹ワクチン市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
Highlights
The global Measles and Rubella Vaccines market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Measles and Rubella Vaccines is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Measles and Rubella Vaccines is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Measles and Rubella Vaccines include Serum Institute of India Ltd., Merck & Co. Inc., GlaxoSmithKline Inc. and Takeda Pharmaceutical Company, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Measles and Rubella Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Measles and Rubella Vaccines.
The Measles and Rubella Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Measles and Rubella Vaccines market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Measles and Rubella Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Serum Institute of India Ltd.
Merck & Co. Inc.
GlaxoSmithKline Inc.
Takeda Pharmaceutical Company
Segment by Type
Monovalent Vaccines
Multivalent Vaccines
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Measles and Rubella Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Measles and Rubella Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Measles and Rubella Vaccines Market Overview
1.1 Product Overview and Scope of Measles and Rubella Vaccines
1.2 Measles and Rubella Vaccines Segment by Type
1.2.1 Global Measles and Rubella Vaccines Market Value Comparison by Type (2023-2029)
1.2.2 Monovalent Vaccines
1.2.3 Multivalent Vaccines
1.3 Measles and Rubella Vaccines Segment by Application
1.3.1 Global Measles and Rubella Vaccines Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Measles and Rubella Vaccines Market Size Estimates and Forecasts
1.4.1 Global Measles and Rubella Vaccines Revenue 2018-2029
1.4.2 Global Measles and Rubella Vaccines Sales 2018-2029
1.4.3 Global Measles and Rubella Vaccines Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Measles and Rubella Vaccines Market Competition by Manufacturers
2.1 Global Measles and Rubella Vaccines Sales Market Share by Manufacturers (2018-2023)
2.2 Global Measles and Rubella Vaccines Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Measles and Rubella Vaccines Average Price by Manufacturers (2018-2023)
2.4 Global Measles and Rubella Vaccines Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Measles and Rubella Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Measles and Rubella Vaccines, Product Type & Application
2.7 Measles and Rubella Vaccines Market Competitive Situation and Trends
2.7.1 Measles and Rubella Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Measles and Rubella Vaccines Players Market Share by Revenue
2.7.3 Global Measles and Rubella Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Measles and Rubella Vaccines Retrospective Market Scenario by Region
3.1 Global Measles and Rubella Vaccines Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Measles and Rubella Vaccines Global Measles and Rubella Vaccines Sales by Region: 2018-2029
3.2.1 Global Measles and Rubella Vaccines Sales by Region: 2018-2023
3.2.2 Global Measles and Rubella Vaccines Sales by Region: 2024-2029
3.3 Global Measles and Rubella Vaccines Global Measles and Rubella Vaccines Revenue by Region: 2018-2029
3.3.1 Global Measles and Rubella Vaccines Revenue by Region: 2018-2023
3.3.2 Global Measles and Rubella Vaccines Revenue by Region: 2024-2029
3.4 North America Measles and Rubella Vaccines Market Facts & Figures by Country
3.4.1 North America Measles and Rubella Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Measles and Rubella Vaccines Sales by Country (2018-2029)
3.4.3 North America Measles and Rubella Vaccines Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Measles and Rubella Vaccines Market Facts & Figures by Country
3.5.1 Europe Measles and Rubella Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Measles and Rubella Vaccines Sales by Country (2018-2029)
3.5.3 Europe Measles and Rubella Vaccines Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Measles and Rubella Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Measles and Rubella Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Measles and Rubella Vaccines Sales by Country (2018-2029)
3.6.3 Asia Pacific Measles and Rubella Vaccines Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Measles and Rubella Vaccines Market Facts & Figures by Country
3.7.1 Latin America Measles and Rubella Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Measles and Rubella Vaccines Sales by Country (2018-2029)
3.7.3 Latin America Measles and Rubella Vaccines Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Measles and Rubella Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Measles and Rubella Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Measles and Rubella Vaccines Sales by Country (2018-2029)
3.8.3 Middle East and Africa Measles and Rubella Vaccines Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Measles and Rubella Vaccines Sales by Type (2018-2029)
4.1.1 Global Measles and Rubella Vaccines Sales by Type (2018-2023)
4.1.2 Global Measles and Rubella Vaccines Sales by Type (2024-2029)
4.1.3 Global Measles and Rubella Vaccines Sales Market Share by Type (2018-2029)
4.2 Global Measles and Rubella Vaccines Revenue by Type (2018-2029)
4.2.1 Global Measles and Rubella Vaccines Revenue by Type (2018-2023)
4.2.2 Global Measles and Rubella Vaccines Revenue by Type (2024-2029)
4.2.3 Global Measles and Rubella Vaccines Revenue Market Share by Type (2018-2029)
4.3 Global Measles and Rubella Vaccines Price by Type (2018-2029)
5 Segment by Application
5.1 Global Measles and Rubella Vaccines Sales by Application (2018-2029)
5.1.1 Global Measles and Rubella Vaccines Sales by Application (2018-2023)
5.1.2 Global Measles and Rubella Vaccines Sales by Application (2024-2029)
5.1.3 Global Measles and Rubella Vaccines Sales Market Share by Application (2018-2029)
5.2 Global Measles and Rubella Vaccines Revenue by Application (2018-2029)
5.2.1 Global Measles and Rubella Vaccines Revenue by Application (2018-2023)
5.2.2 Global Measles and Rubella Vaccines Revenue by Application (2024-2029)
5.2.3 Global Measles and Rubella Vaccines Revenue Market Share by Application (2018-2029)
5.3 Global Measles and Rubella Vaccines Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Serum Institute of India Ltd.
6.1.1 Serum Institute of India Ltd. Corporation Information
6.1.2 Serum Institute of India Ltd. Description and Business Overview
6.1.3 Serum Institute of India Ltd. Measles and Rubella Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Serum Institute of India Ltd. Measles and Rubella Vaccines Product Portfolio
6.1.5 Serum Institute of India Ltd. Recent Developments/Updates
6.2 Merck & Co. Inc.
6.2.1 Merck & Co. Inc. Corporation Information
6.2.2 Merck & Co. Inc. Description and Business Overview
6.2.3 Merck & Co. Inc. Measles and Rubella Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Merck & Co. Inc. Measles and Rubella Vaccines Product Portfolio
6.2.5 Merck & Co. Inc. Recent Developments/Updates
6.3 GlaxoSmithKline Inc.
6.3.1 GlaxoSmithKline Inc. Corporation Information
6.3.2 GlaxoSmithKline Inc. Description and Business Overview
6.3.3 GlaxoSmithKline Inc. Measles and Rubella Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.3.4 GlaxoSmithKline Inc. Measles and Rubella Vaccines Product Portfolio
6.3.5 GlaxoSmithKline Inc. Recent Developments/Updates
6.4 Takeda Pharmaceutical Company
6.4.1 Takeda Pharmaceutical Company Corporation Information
6.4.2 Takeda Pharmaceutical Company Description and Business Overview
6.4.3 Takeda Pharmaceutical Company Measles and Rubella Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Takeda Pharmaceutical Company Measles and Rubella Vaccines Product Portfolio
6.4.5 Takeda Pharmaceutical Company Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Measles and Rubella Vaccines Industry Chain Analysis
7.2 Measles and Rubella Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Measles and Rubella Vaccines Production Mode & Process
7.4 Measles and Rubella Vaccines Sales and Marketing
7.4.1 Measles and Rubella Vaccines Sales Channels
7.4.2 Measles and Rubella Vaccines Distributors
7.5 Measles and Rubella Vaccines Customers
8 Measles and Rubella Vaccines Market Dynamics
8.1 Measles and Rubella Vaccines Industry Trends
8.2 Measles and Rubella Vaccines Market Drivers
8.3 Measles and Rubella Vaccines Market Challenges
8.4 Measles and Rubella Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer